ArticleSignal transduction and targeted therapy2023

Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors.

Bopei Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.